Esperion Therapeutics Inc (ESPR)
1.94
+0.07
(+3.75%)
USD |
NASDAQ |
Apr 19, 16:00
1.95
+0.01
(+0.52%)
After-Hours: 19:26
Esperion Therapeutics Cash from Operations (TTM): -135.49M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -135.49M |
September 30, 2023 | -140.90M |
June 30, 2023 | -164.41M |
March 31, 2023 | -190.19M |
December 31, 2022 | -174.83M |
September 30, 2022 | -190.06M |
June 30, 2022 | -216.40M |
March 31, 2022 | -213.73M |
December 31, 2021 | -263.81M |
September 30, 2021 | -274.65M |
June 30, 2021 | -292.16M |
March 31, 2021 | -104.90M |
December 31, 2020 | -85.18M |
September 30, 2020 | -66.62M |
June 30, 2020 | -37.98M |
March 31, 2020 | -231.38M |
December 31, 2019 | -70.34M |
September 30, 2019 | -49.04M |
June 30, 2019 | -28.54M |
March 31, 2019 | -13.73M |
December 31, 2018 | -148.64M |
September 30, 2018 | -154.82M |
June 30, 2018 | -153.18M |
Date | Value |
---|---|
March 31, 2018 | -140.21M |
December 31, 2017 | -131.30M |
September 30, 2017 | -112.74M |
June 30, 2017 | -91.16M |
March 31, 2017 | -72.24M |
December 31, 2016 | -47.73M |
September 30, 2016 | -39.86M |
June 30, 2016 | -37.39M |
March 31, 2016 | -38.70M |
December 31, 2015 | -38.16M |
September 30, 2015 | -37.92M |
June 30, 2015 | -34.72M |
March 31, 2015 | -32.18M |
December 31, 2014 | -32.02M |
September 30, 2014 | -31.34M |
June 30, 2014 | -27.49M |
March 31, 2014 | -24.59M |
December 31, 2013 | -18.11M |
September 30, 2013 | -12.95M |
June 30, 2013 | -11.08M |
March 31, 2013 | -10.75M |
December 31, 2012 | -10.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-292.16M
Minimum
Jun 2021
-28.54M
Maximum
Jun 2019
-154.24M
Average
-164.41M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
United Therapeutics Corp | 978.00M |
Masimo Corp | 94.10M |
Heron Therapeutics Inc | -58.79M |
Aldeyra Therapeutics Inc | -30.33M |
Aravive Inc (DELISTED) | -59.45M |